Posts Tagged ‘Antibody Profiling’

Antibody Profiling

Assays to Predict Developability Antibody therapies are not novel. The first FDA approval and commercialization for an antibody therapeutic was in 1986 for Orthoclone OKT3, which was approved for prevention of kidney transplant rejection (Ecker et al. 2015). As of today, there are 78 monoclonal antibody treatments on the market to treat a wide variety…

Read More